Literature DB >> 21037255

The future of clinical trials in secondary prevention after acute coronary syndromes.

Héctor Bueno1, Paul W Armstrong, Martin J Buxton, Nicolas Danchin, Jacobus Lubsen, Edmond Roland, Freek W Verheugt, Andrew Zalewski, Neville Jackson, Michel Komajda, Ph Gabriel Steg.   

Abstract

Mesh：

Year:  2010        PMID： 21037255     DOI： 10.1093/eurheartj/ehq388

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Secondary prevention following myocardial infarction--there is still more to be done.

Authors:  Karl Werdan
Journal:  Dtsch Arztebl Int       Date:  2011-12-16       Impact factor: 5.594

Review 2.  Individual and composite study endpoints: separating the wheat from the chaff.

Authors:  Robert Goldberg; Joel M Gore; Bruce Barton; Jerry Gurwitz
Journal:  Am J Med       Date:  2014-01-28       Impact factor: 4.965

3.  Rationale, design and methods of CTCA-PRORECAD (Computed Tomography Coronary Angiography Prognostic Registry for Coronary Artery Disease): a multicentre and multivendor registry.

Authors:  E Maffei; M Midiri; V Russo; M Rengo; C Tedeschi; P Spagnolo; S Seitun; M Francone; A I Guaricci; N Carrabba; R Malagò; A Cuocolo; T Arcadi; O A Catalano; F Cademartiri
Journal:  Radiol Med       Date:  2013-01-28       Impact factor: 3.469

4.  Bin-CE: A comprehensive web application to decide upon the best set of outcomes to be combined in a binary composite endpoint.

Authors:  Josep Ramon Marsal; Ignacio Ferreira-González; Aida Ribera; Gerard Oristrell; Jose Ignacio Pijoan; David García-Dorado
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

5.  Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.

Authors:  Anna Meta Dyrvig Kristensen; Ann Bovin; Ann Dorthe Zwisler; Charlotte Cerquira; Christian Torp-Pedersen; Hans Erik Bøtker; Ida Gustafsson; Karsten Tange Veien; Kristian Korsgaard Thomsen; Michael Hecht Olsen; Mogens Lytken Larsen; Olav Wendelboe Nielsen; Per Hildebrandt; Sussie Foghmar; Svend Eggert Jensen; Theis Lange; Thomas Sehested; Tomas Jernberg; Dan Atar; Borja Ibanez; Eva Prescott
Journal:  Trials       Date:  2020-05-23       Impact factor: 2.279

Review 6.  MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic Review.

Authors:  Jennifer Y Barraclough; Michelyn Joan; Mugdha V Joglekar; Anandwardhan A Hardikar; Sanjay Patel
Journal:  Cells       Date:  2019-12-04       Impact factor: 6.600

7.  Participation in disease management programs and major adverse cardiac events in patients after acute myocardial infarction: a longitudinal study based on registry data.

Authors:  Christian Fischer; Jens Höpner; Saskia Hartwig; Michel Noutsias; Rafael Mikolajczyk
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.